A Phase 3 Randomized Study of Selumetinib Versus Carboplatin/Vincristine in Newly Diagnosed or Previously Untreated Neurofibromatosis Type 1 (NF1) Associated Low-Grade Glioma (LGG)
COG-ACNS1831
NCT03871257
 Recruiting
|
CENTRE HOSPITALIER UNIVERSITAIRE SAINTE-JUSTINE
|
|
Linda Hershon
514-345-4931 poste 5899
|
A Phase 2 Trial of Chemotherapy Followed by Response-Based Whole Ventricular &Amp; Spinal Canal Irradiation (WVSCI) for Patients With Localized Non-Germinomatous Central Nervous System Germ Cell Tumor
ACNS2021
NCT04684368
Recruiting
|
CENTRE HOSPITALIER UNIVERSITAIRE SAINTE-JUSTINE
|
|
Clemence Noury
514-345-4931 poste 6848
|
Phase III Trial of Observation Versus Irradiation for a Gross Totally Resected Grade II Meningioma
NRG-BN003
NCT03180268
Recruiting
|
CENTRE UNIVERSITAIRE DE SANTE MCGILL
 SITE GLEN
|
Phase III |
Ginette Ricard
514-934-1934 poste 43186
|
A Randomized Phase 3 Open-Label Study To Evaluate the Efficacy and Safety of Eflornithine With Lomustine Compared to Lomustine Alone in Patients With AA That Progress/Recur After Irradiation and Adjuvant Temozolomide Chemotherapy
Orbus OT-15-0011
NCT02796261
Recruiting
|
CENTRE UNIVERSITAIRE DE SANTE MCGILL
HOPITAL NEUROLOGIQUE DE MONTREAL
|
Phase III |
Gabriele Riva
514-398-6907
|
A Multicenter Randomized Phase III Trial on INTraoperative RAdiotherapy in Newly Diagnosed GliOblastoma Multiforme
INTRAGO II
NCT02685605
Recruiting
|
CENTRE UNIVERSITAIRE DE SANTE MCGILL
HOPITAL NEUROLOGIQUE DE MONTREAL
|
Phase III |
Gabriele Riva
514-398-6907
|
Metformin and Neo-adjuvant Temozolomide and Hypofractionated Accelerated Limited-margin Radiotherapy Followed by Adjuvant Temozolomide in Patients With Glioblastoma Multiforme
MUHC ID: 4315 (M-HARTT STUDY)
NCT02780024
Recruiting
|
CENTRE UNIVERSITAIRE DE SANTE MCGILL
SITE GLEN
|
Phase II |
Marianna Perna
514-934-1934 poste 43191
|
Randomized Phase II Trial of Hypofractionated Dose-Escalated Photon IMRT or Proton Beam Therapy Versus Conventional Photon Irradiation With Concomitant and Adjuvant Temozolomide in Patients With Newly Diagnosed Glioblastoma
BN001
NCT02179086
Recruiting
|
CENTRE UNIVERSITAIRE DE SANTE MCGILL
SITE GLEN
|
Phase II |
Marie-Claude Joncas
514-934-1934 poste 34906
|
A Phase III Trial of Stereotactic Radiosurgery Compared With Whole Brain Radiotherapy (WBRT) for 5-15 Brain Metastases
CE.7
NCT03550391
Recruiting
|
CENTRE UNIVERSITAIRE DE SANTE MCGILL
SITE GLEN
|
|
Evelyn Ortega
514-934-1934 poste 48354
|
A Phase 3 Randomized Study of Selumetinib Versus Carboplatin/Vincristine in Newly Diagnosed or Previously Untreated Neurofibromatosis Type 1 (NF1) Associated Low-Grade Glioma (LGG)
COG-ACNS1831
NCT03871257
Recruiting
|
CENTRE UNIVERSITAIRE DE SANTE MCGILL
HOPITAL DE MONTREAL POUR ENFANTS
|
|
Stephanie Badour
514-412-4400 poste 23807
|
Phase III Randomized Double-blind Placebo-controlled Trial of Metformin for Cognitive Recovery and White Matter Growth in Paediatric Medulloblastoma Patients
Met Med Can
NCT05230758
Recruiting
|
CENTRE UNIVERSITAIRE DE SANTE MCGILL
HOPITAL DE MONTREAL POUR ENFANTS
|
|
Stephanie Badour
514-412-4400 poste 23807
|
Groupe d'étude en oncologie du Québec